Haloxyfop-P-Methyl

Haloxyfop-P-Methyl

SCHEMBL7199533

COC(=O)C(C)Oc1ccc(Oc2ccc(Cl)cc2Cl)cc1.COC(=O)C(C)Oc1ccc(Oc2ncc(C(F)(F)F)cc2Cl)cc1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.56
SMN1; SMN2 Q16637 6/20 0.52
ALDH1A1 P00352 3/20 0.52
L3MBTL1 Q9Y468 2/20 0.51
LIPE Q05469 1/20 0.50
KMT2A Q03164 4/20 0.49
ATM Q13315 1/20 0.49
FFAR1 O14842 1/20 0.49
MEN1 O00255 3/20 0.48
MAPT P10636 3/20 0.48
MAPK1 P28482 1/20 0.48
HPGD P15428 1/20 0.46
HTT P42858 2/20 0.46
POLB P06746 1/20 0.46
PPARG P37231 1/20 0.46
XBP1 P17861 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Haloxyfop-P-Methyl SCHEMBL29514646 0.91 LMNA (0.65) LMNASMN1; SMN2ALDH1A1L3MBTL1LIPE
Haloxyfop-P-Methyl SCHEMBL29370417 0.91 LMNA (0.65) LMNASMN1; SMN2ALDH1A1L3MBTL1LIPE
Haloxyfop-P-Methyl SCHEMBL54814 0.91 LMNA (0.65) LMNASMN1; SMN2ALDH1A1L3MBTL1LIPE
Haloxyfop-P-Methyl SCHEMBL54547 0.91 LMNA (0.65) LMNASMN1; SMN2ALDH1A1L3MBTL1LIPE
Diclofop-Methyl SCHEMBL10670222 0.86 FFAR1 (0.48) LMNASMN1; SMN2L3MBTL1KMT2AFFAR1
SCHEMBL9367419 0.84 TDP1 (0.47) LMNASMN1; SMN2ALDH1A1L3MBTL1LIPE
SCHEMBL732095 0.84 FFAR1 (0.58) L3MBTL1KMT2AFFAR1MEN1MAPT
Fluazifop SCHEMBL9789176 0.84 LIPE (0.49) LMNASMN1; SMN2L3MBTL1LIPEKMT2A
SCHEMBL10573318 0.84 LMNA (0.56) LMNASMN1; SMN2ALDH1A1LIPEKMT2A
SCHEMBL9362370 0.83 LIPE (0.60) LMNASMN1; SMN2ALDH1A1L3MBTL1LIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003077651-A1 MICROPARTICLE FORMULATION WITH REDUCED AQUATIC TOXICITY CHEMINOVA A/S (DK) 2003-09-25 WO disclosed